NCT06392776

Early Diagnosis and Treatment of Undiagnosed Asthma or COPD: THE UCAP 2 TRIAL

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 420 (estimated)
• Sponsor: Ottawa Hospital Research Institute · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Our research group has found that Canadians with undiagnosed asthma or chronic obstructive pulmonary disease (COPD) have increased respiratory symptoms and worse health-related quality of life. The investigators recently developed and validated an on-line questionnaire to accurately identify these symptomatic, undiagnosed individuals. The investigators will advertise in the community asking individuals to complete the on-line questionnaire at home, at their leisure, to determine if they are at risk of asthma or COPD. Those at risk will be invited to participate in a randomized, controlled clinical trial to determine whether early diagnosis of previously undiagnosed asthma or COPD and subsequent treatment by the primary care practitioner will improve their quality of life.

Conditions

• COPD
• Asthma

Interventions

Type	Name	Description
OTHER	Early diagnosis and treatment	Early diagnosis of previously undiagnosed asthma or COPD and subsequent treatment by a primary care practitioner

Timeline

• Start date: 2024-07-16
• Primary completion: 2028-12-01
• Completion: 2029-12-01
• First posted: 2024-04-30
• Last updated: 2026-01-14

Locations

4 sites across 1 country: Canada